| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Potassium voltage-gated channel, Isk-related family, member 1 (KCNE1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY426845 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, Isk-related family, member 1 (KCNE1), transcript variant 4 from ORIGENE TECHNOLOGIES | LY426846 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, KQT-like subfamily, member 3 (KCNQ3) from ORIGENE TECHNOLOGIES | LY417937 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, KQT-like subfamily, member 1 (KCNQ1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424853 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, KQT-like subfamily, member 1 (KCNQ1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424989 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, KQT-like subfamily, member 1 (KCNQ1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405589 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, KQT-like subfamily, member 2 (KCNQ2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY406840 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, KQT-like subfamily, member 2 (KCNQ2), transcript variant 5 from ORIGENE TECHNOLOGIES | LY406842 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, KQT-like subfamily, member 4 (KCNQ4), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417828 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, KQT-like subfamily, member 4 (KCNQ4), transcript variant 2 from ORIGENE TECHNOLOGIES | LY430345 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, KQT-like subfamily, member 4 (KCNQ4), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406774 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, KQT-like subfamily, member 5 (KCNQ5), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412712 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, Shab-related subfamily, member 1 (KCNB1) from ORIGENE TECHNOLOGIES | LY401551 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, shaker-related subfamily, beta member 3 (KCNAB3) from ORIGENE TECHNOLOGIES | LY417789 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, shaker-related subfamily, beta member 1 (KCNAB1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY430344 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, shaker-related subfamily, beta member 1 (KCNAB1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY406773 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, shaker-related subfamily, beta member 1 (KCNAB1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY418655 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, shaker-related subfamily, beta member 1 (KCNAB1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY429147 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, shaker-related subfamily, beta member 1 (KCNAB1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY403531 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, shaker-related subfamily, beta member 2 (KCNAB2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY418536 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, shaker-related subfamily, beta member 2 (KCNAB2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406850 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) (KCNA1) from ORIGENE TECHNOLOGIES | LY400085 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, shaker-related subfamily, member 10 (KCNA10) from ORIGENE TECHNOLOGIES | LY401703 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, shaker-related subfamily, member 2 (KCNA2) from ORIGENE TECHNOLOGIES | LY401550 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, shaker-related subfamily, member 3 (KCNA3) from ORIGENE TECHNOLOGIES | LY419451 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, shaker-related subfamily, member 4 (KCNA4) from ORIGENE TECHNOLOGIES | LY419452 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, shaker-related subfamily, member 5 (KCNA5) from ORIGENE TECHNOLOGIES | LY419453 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium voltage-gated channel, shaker-related subfamily, member 7 (KCNA7) from ORIGENE TECHNOLOGIES | LY403125 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain binding 2 (LDB2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400529 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain binding 1 (LDB1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY418367 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain binding 2 (LDB2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY427279 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain binding 3 (LDB3), transcript variant 3 from ORIGENE TECHNOLOGIES | LY421586 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain binding 3 (LDB3), transcript variant 4 from ORIGENE TECHNOLOGIES | LY421587 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain containing 2 (LIMD2) from ORIGENE TECHNOLOGIES | LY410780 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain containing preferred translocation partner in lipoma (LPP), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417214 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain containing preferred translocation partner in lipoma (LPP), transcript variant 2 from ORIGENE TECHNOLOGIES | LY433345 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain kinase 1 (LIMK1) from ORIGENE TECHNOLOGIES | LY400838 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain kinase 2 (LIMK2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY422193 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain kinase 2 (LIMK2), transcript variant 2b from ORIGENE TECHNOLOGIES | LY413829 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain 7 (LMO7), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417355 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain only 4 (LMO4) from ORIGENE TECHNOLOGIES | LY402024 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain only 2 (rhombotin-like 1) (LMO2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417218 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain only 2 (rhombotin-like 1) (LMO2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY432149 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain only 2 (rhombotin-like 1) (LMO2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY428033 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain only 2 (rhombotin-like 1) (LMO2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY428034 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain only 3 (rhombotin-like 2) (LMO3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402699 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain only 3 (rhombotin-like 2) (LMO3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY424337 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domain only 1 (rhombotin 1) (LMO1) from ORIGENE TECHNOLOGIES | LY419398 | 100 ug | ORIGENE TECHNOLOGIES |
| LIM domains containing 1 (LIMD1) from ORIGENE TECHNOLOGIES | LY415413 | 100 ug | ORIGENE TECHNOLOGIES |
| LIME1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN401909 | 1 kit | ORIGENE TECHNOLOGIES |